![Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data | The European Journal of Health Economics Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data | The European Journal of Health Economics](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs10198-022-01429-x/MediaObjects/10198_2022_1429_Fig2_HTML.png)
Generating EQ-5D-5L health utility scores from BASDAI and BASFI: a mapping study in patients with axial spondyloarthritis using longitudinal UK registry data | The European Journal of Health Economics
![Frontiers | Comprehensive AI-assisted tool for ankylosing spondylitis based on multicenter research outperforms human experts Frontiers | Comprehensive AI-assisted tool for ankylosing spondylitis based on multicenter research outperforms human experts](https://www.frontiersin.org/files/Articles/1063633/fpubh-11-1063633-HTML/image_m/fpubh-11-1063633-t002.jpg)
Frontiers | Comprehensive AI-assisted tool for ankylosing spondylitis based on multicenter research outperforms human experts
![Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this? | Arthritis Research & Therapy | Full Text Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this? | Arthritis Research & Therapy | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs13075-023-03055-1/MediaObjects/13075_2023_3055_Fig1_HTML.png)
Sustained low functional impairment in axial spondyloarthritis (axSpA): which are the primary outcomes that should be targeted to achieve this? | Arthritis Research & Therapy | Full Text
![ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis - ACR Meeting Abstracts, asdas - designco-india.com ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis - ACR Meeting Abstracts, asdas - designco-india.com](https://www.healio.com/~/media/clinical-guidance/ankylosing-spondylitis/assessment-and-treatment/ch12assessmentandmonitoring/table121.webp)
ASDAS Is More Important Than BASDAI in Advanced Ankylosing Spondylitis - ACR Meeting Abstracts, asdas - designco-india.com
![Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. - Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. -](https://europepmc.org/articles/PMC4629489/bin/rhu-21-300-g002.jpg)
Routine Assessment of Patient Index Data (RAPID3) and Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) Scores Yield Similar Information in 85 Korean Patients With Ankylosing Spondylitis Seen in Usual Clinical Care. -
![Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis]., asdas - thirstymag.com Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis]., asdas - thirstymag.com](https://www.jrheum.org/content/jrheum/48/9/1395/F1.large.jpg)
Scoring of disease activity using BASDAI and ASDAS method in ankylosing spondylitis]., asdas - thirstymag.com
![Cureus | Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis | Article Cureus | Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis | Article](https://assets.cureus.com/uploads/figure/file/690824/article_river_9df0e39024e311eebcab9d48a85c7234-figure-corrected3.png)
Cureus | Spinal Mobility Limitation Can Be the Main Reason of Kinesiophobia in Ankylosing Spondylitis | Article
![Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece | Clinical Drug Investigation Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece | Clinical Drug Investigation](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs40261-023-01333-z/MediaObjects/40261_2023_1333_Fig2_HTML.png)
Cost Effectiveness of Tofacitinib for the Treatment of Active Ankylosing Spondylitis in Greece | Clinical Drug Investigation
![Full article: Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy Full article: Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy](https://www.tandfonline.com/cms/asset/6cc62f10-60c0-4f5b-afb6-b2e9f71e56ab/irhe_a_2007609_f0002_oc.jpg)
Full article: Worse scores but similar patterns of disease activity: interpreting outcomes in women with axial spondyloarthropathy
![Measuring quality of life of patients with axial spondyloarthritis for economic evaluation. - Abstract - Europe PMC Measuring quality of life of patients with axial spondyloarthritis for economic evaluation. - Abstract - Europe PMC](https://europepmc.org/articles/PMC8860088/bin/rmdopen-2021-001955f03.jpg)